Mihai Manolache, PhD
President & CEO – CEBIS International SAGL - Switzerland
Mihai Manolache is the founder of CEBIS International and he holds a PhD in Biostatistics and a Master's Degree in Biostatistics. Mihai completed a Post-Graduate course in Immunology and Genetics at Harvard Medical School, Graduated from Law School, specializing in medical research laws and regulations, and graduated from Economics, specializing in Administrative Sciences, from the University of Bucharest.
Mihai has expertise in planning, managing and coordinating clinical studies globally. He has directed more than 200 international clinical studies including managing research sites across Romania, Bulgaria, Croatia, Hungary, Serbia and Montenegro, Macedonia, Moldova, Greece, Turkey, India, Spain, Switzerland, Italy, Germany, Ukraine, Estonia, Latvia, and Lithuania. Mihai has managed clinical trials in a variety of therapeutic areas including cardiology, oncology, diabetes, CNS, hematology, urology, gastroenterology, pediatrics, HIV, immunology, ObGyn, respiratory, and dermatology.
Prior to the formation of CEBIS, Mihai was the Clinical Operations and Business Development Manager for a Global US-Michigan Based Contract Research Organization, responsible for setting up and developing clinical research business in the EMEA region.
Mihai has published several papers and given more than 120 conference presentations in areas ranging from clinical research, clinical development, regulatory affairs, medical writing, biostatistics, project management, good clinical practices, ethics in research and risk management in research.
Mihai believes that more specialized needs around patient support will continue to grow around the world, especially in emerging markets. With a growth in new hi-tech therapies, patients require more customized options to solve their adherence needs, and pharmaceutical companies are changing how they address those needs.